Suchergebnisse - Isabelle Ravelingien

  • Treffer 1 - 6 von 6
Treffer weiter einschränken
  1. 1
    Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

    Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial von Frédéric Houssiau, David D’Cruz, Shirish Sangle, Philippe Rémy, Carlos Vasconcelos, Radmila Petrović, Christoph Fiehn, Enrique de Ramón Garrido, Inge-Magrethe Gilboe, Maria G. Tektonidou, Daniël Blockmans, Isabelle Ravelingien, Véronique Le Guern, Geneviève Depresseux, Loı̈c Guillevin, Ricard Cervera

    Veröffentlicht 2010
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Long-term follow-up of the <i>MAINTAIN</i> Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis

    Long-term follow-up of the <i>MAINTAIN</i> Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis von Farah Tamirou, David D’Cruz, Shirish Sangle, Philippe Rémy, Carlos Vasconcelos, Christoph Fiehn, María del Mar Ayala Gutiérrez, Inge-Magrethe Gilboe, Maria G. Tektonidou, Daniël Blockmans, Isabelle Ravelingien, Véronique Le Guern, Geneviève Depresseux, Loı̈c Guillevin, Ricard Cervera, Frédéric Houssiau

    Veröffentlicht 2015
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial

    Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial von Maria Stoenoiu, Selda Aydın, Maria G. Tektonidou, Isabelle Ravelingien, Véronique Le Guern, Christoph Fiehn, Philippe Rémy, Michel Delahousse, P Petera, T. Quemeneur, Carlos Vasconcelos, David D’Cruz, I-M Gilboe, Michel Jadoul, A. Karras, G Depresseux, Loı̈c Guillevin, Ricard Cervera, J.-P. Cosyns, Frédéric Houssiau

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial

    Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the random... von Patrick Verschueren, Diederik De Cock, Luk Corluy, Rik Joos, C. Langenaken, V. Taelman, F. Raeman, Isabelle Ravelingien, K. Vandevyvere, Jan Lenaerts, Elke Geens, Piet Geusens, J. Vanhoof, Anne Durnez, J Remans, Bert Vander Cruyssen, E. Van Essche, A. Sileghem, G. De Brabanter, Johan Joly, Kristien Van der Elst, Sabrina Meyfroidt, René Westhovens

    Veröffentlicht 2015
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial

    Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid a... von Patrick Verschueren, Diederik De Cock, Luk Corluy, Rik Joos, C. Langenaken, V. Taelman, F. Raeman, Isabelle Ravelingien, K. Vandevyvere, Jan Lenaerts, Elke Geens, Piet Geusens, J. Vanhoof, Anne Durnez, J Remans, Bert Vander Cruyssen, E. Van Essche, A. Sileghem, G. De Brabanter, Johan Joly, Sabrina Meyfroidt, Kristien Van der Elst, René Westhovens

    Veröffentlicht 2014
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA

    Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA von Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Patrick Verschueren, B. Maeyaert, G. De Brabanter, Mieke Devinck, C. Langenaken, J. Lenaerts, L Corluy, J Remans, Bert Vander Cruyssen, Isabelle Ravelingien, E. Van Essche, K. Vandevyvere, Anne Durnez, August Verbruggen, Elke Geens, F. Raeman, Rik Joos, Kurt de Vlam, V. Taelman, J. Vanhoof, Michiel Coppens, Piet Geusens, A. Sileghem, Paul G.A. Volders, Filip Van den Bosch, Patrick Verschueren, R Westhovens

    Veröffentlicht 2019
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: